Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier

Authors:
  • TLTianyu Liu
    Tianyu Liu
  • CYChen Yan
    Chen Yan
  • RXRunxiang Xie
    Runxiang Xie
  • ZGZixuan Guo
    Zixuan Guo
  • SWSinan Wang
    Sinan Wang
  • YZYujie Zhang
    Yujie Zhang
  • ZLZhengxiang Li
    Zhengxiang Li
  • BWBangmao Wang
    Bangmao Wang

Abstract
Nonalcoholic fatty liver disease (NAFLD), as a common chronic liver disorder, is prevalent in the world. Recent evidence demonstrates that the “gut-liver axis” is related well to the progression of NAFLD, which regards gut microbiota and intestinal barrier as two critical factors correlated with NAFLD. Diammonium glycyrrhizinate (DG), a compound of natural bioactive pentacyclic triterpenoid glycoside, is the main component of licorice roots extracts. The anti-inflammatory and liver protection effects of DG have already been reported, but to date, the mechanism has not been fully elucidated. In this research, we observed that DG reduced body weight, liver steatosis, as well as hepatic inflammatory in NAFLD model mice induced by high fat diet. Illumina sequencing of the 16S rRNA revealed that DG intervention notably altered the composition of the gut microbiota in NAFLD mice. The richness of gut microbiota was significantly increased by DG. Specifically, DG reduced the Firmicutes-to-Bacteroidetes ratio and the endotoxin-producing bacteria such as Desulfovibrio, and elevated the abundance of probiotics such as Proteobacteria and Lactobacillus. Interestingly DG could augment the levels of short-chain fatty acids (SCFAs)-producing bacteria such as Ruminococcaceae and Lachnospiraceae and promote SCFAs production. In addition, DG supplementation dramatically alleviated the intestinal low-grade inflammation. Meanwhile, DG improved the expression of tight junction proteins, the goblet cells number and mucin secretion, and sequentially enhanced the function of intestinal barrier. Collectively, the prevention of NAFLD by DG might be mediated by modulating gut microbiota and restoring intestinal barrier.
Funding Information
  • National Natural Science Foundation of China (81741075)
  • China Foundation for Hepatitis Prevention and Control (TQGB20150215)
  • Tianjin Research Program of Application Foundation and Advanced Technology (17JCYBJC24900)
  • Tianjin Medical University General Hospital (ZYYFY2017020)

This publication has 69 references indexed in Scilit: